Agilent Technologies management check

A · Health Care · Life Sciences Tools & Services · CEO Padraig Mcdonnell

Filings as of

55
Management score, ranked 386th of 487 · 48th of 60 in Health Care4 good · 1 to watch · 2 flaggedStrongest: clean books · Weakest: stable leadership · Best and worst run in Health Care →

The seven checks

  • Flag

    Have owners done well?

    Trailed its chosen peersOwners$148Peers$194

    What $100 became since fiscal 2021

    2130th
    Detail

    $100 invested at the start of fiscal 2021 grew to $148, against $194 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    9068th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.80 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Good

    What does the CEO cost owners?

    0.8% of net income

    $12.8m pay · $1.6bn net income, FY2025

    0.1%1%3%10%
    5858th
    Detail

    $12.8m of reported pay in fiscal 2025, against $1.6bn of net income.

  • Watch

    Do they own the stock?

    CEO stake ≈ 0.9 years of pay

    65,566 shares ≈ $11.4m

    0.1y1y5y20y100y

    6 mo: ▲ $0 bought · ▼ $313k sold

    3232nd
    Detail

    The CEO holds 65,566 shares, directly or through trusts (unvested awards not counted): about 0.9 years of pay. Light activity: no buys, $313k sold in six months.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 307m2025 · 285m

    Diluted shares −1.9% a year; flagged above +2%

    0%10%20%

    Stock pay 1.8% of revenue

    7365th
    Detail

    Diluted shares changed -1.9% a year over the last three fiscal years. Stock-based pay was 1.8% of revenue in the latest year.

  • Flag

    Is leadership stable?

    2 CEOs in the pay table

    15 filings under 8-K 5.02 in 3 years

    0101420+

    CEOs: Mr. McMullen, Mr. McDonnell

    107th
    Detail

    CEOs in the pay table: Mr. McMullen, Mr. McDonnell. 15 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed February 6, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$15.9m$31.8m$10020212022202320242025$148$194

Pay tied most to AdjustedEPS

Other key measuresAdjusted Operating MarginAdjusted Earnings Per Share (EPS)Total Shareholder Return (TSR)Adjusted Revenue

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Mr. McDonnell$12.8m$14.6m$3.8m$148$194$1.6bn
2024Mr. McDonnell, Mr. McMullen$16.6m$21.2m$5.9m$131$174$1.5bn
2023Mr. McMullen$16.0m$1.0m$3.7m$103$134$1.2bn
2022Mr. McMullen$16.6m$10.5m$4.2m$137$130$1.3bn
2021Mr. McMullen$16.0m$31.8m$3.8m$155$140$1.2bn

Insiders and the CEO's stakeQuiet

President and CEO
Padraig Mcdonnell
Shares held
65,566
At that filing's price
≈ $11.4m
Latest Form 4
Nov 13, 2026

Light activity: no buys, $313k sold in six months.

Open-market trades by officers and directors since May 21, 2026.

  • SoldMikael DolstenDirector$313kSep 4, 2026

Leadership and governance on file

20222023202420252026Leadership 19Votes 5
All 19 filings

Latest shareholder vote results: Mar 20, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $5.4bn returned to owners in buybacks and dividends, 86% of net income, and $603.0m of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$712.0m$1.4bn20212022202320242025Shares307m300m296m291m285m
Show the figures
Fiscal year20212022202320242025
Revenue$6.3bn$6.8bn$6.8bn$6.5bn$6.9bn
Net income$1.2bn$1.3bn$1.2bn$1.3bn$1.3bn
Stock-based pay$110.0m$125.0m$111.0m$129.0m$128.0m
Buybacks$788.0m$1.1bn$575.0m$1.1bn$425.0m
Dividends$236.0m$250.0m$265.0m$274.0m$282.0m
Diluted shares307m300m296m291m285m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.